Managing cardiovascular risk: Reality vs. perception

European Heart Journal, Supplement

Volumn 7, Issue L, 2005, Pages

  Erhardt, Leif R ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Barriers; Cardiovascular risk; Guidelines gap; Obesity; Practice guidelines

Indexed keywords

AWARENESS; CARDIOVASCULAR RISK; CONFERENCE PAPER; DOCTOR PATIENT RELATION; HUMAN; LIFESTYLE; PATIENT EDUCATION; PERCEPTION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 27744513497     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sui080     Document Type: Conference Paper

References (16)

1. De Backer G, Ambrosioni E, Borch-Johnsen K et at.; European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003;10(Suppl. 1);S1-S78.
2. Erhardt L, Pearson TA, Bruckert E et al. Guidelines and their implementation: a discussion document focused on the best approaches to drive improvement. Vasc Dis Prev 2004;1:167-174.
3. Cabana MD, Rand CS, Powe NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-1465.
4. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) Survey. Fam Pract 2002;19:596-604.
5. EUROASPIRE I and II Group. European action on secondary prevention by intervention to reduce events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001;357:995-1001.
6. Pearson TA, Laurora I, Chu H et al. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000;160:459-467.
7. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II. Eur Heart J 2001;22:554-572.
8. Vale MJ, Jelinek MV, Best JD; COACH Study Group. Coaching patients on achieving cardiovascular health. How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000. Med J Aust 2002;176: 211-215.
9. Backlund L, Bring J, Strender L-E. How accurately do general practitioners and students estimate coronary risk in hypercholesterolaemic patients? Prim Health Care Res Dev 2004;5:145-152.
10. Erhardt L, Hobbs FD. Public perceptions of cardiovascular risk in five European countries: the react survey. Int J Clin Pract 2002;56:638-644.
11. Duryee R. The efficacy of inpatient education after myocardial infarction. Heart Lung 1992;21:217-225.
12. Murray PJ. Rehabilitation information and health beliefs in the post-coronary patient: do we meet their information needs? J Adv Nurs 1989;14:686-693.
13. Wynn A. Unwarranted emotional distress in men with ischaemic heart disease (IHD). Med J Aust 1967;2:847-851.
14. Newens AJ, McColl E, Lewin R et al. Cardiac misconceptions and knowledge in nurses caring for myocardial infarction patients. Coronary Health Care 1997;1:83-89.
15. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383-386.
16. Thomson R, Lavender M, Madhok R. How to ensure that guidelines are effective. BMJ 1995;311:237-242.